Plexus Capital and 424 Capital Invest in VaLogic Bio

September 19, 2023

Plexus Capital and 424 Capital announced an investment in VaLogic Bio, a Frederick, Maryland-based provider of GMP compliance software and life-sciences laboratory services. The capital will support VaLogic’s continued growth of its facility monitoring SaaS and professional compliance services for FDA-regulated clients.

Buyers
Plexus Capital, LLC, 424 Capital
Targets
VaLogic Bio
Location
Maryland, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.